JANX
Price
$34.69
Change
-$0.05 (-0.14%)
Updated
Nov 26, 04:59 PM (EDT)
Capitalization
2.09B
100 days until earnings call
Intraday BUY SELL Signals
XNCR
Price
$17.39
Change
+$0.13 (+0.75%)
Updated
Nov 26, 04:59 PM (EDT)
Capitalization
1.23B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

JANX vs XNCR

Header iconJANX vs XNCR Comparison
Open Charts JANX vs XNCRBanner chart's image
Janux Therapeutics
Price$34.69
Change-$0.05 (-0.14%)
Volume$29.15K
Capitalization2.09B
Xencor
Price$17.39
Change+$0.13 (+0.75%)
Volume$37.96K
Capitalization1.23B
JANX vs XNCR Comparison Chart in %
JANX
Daily Signal:
Gain/Loss:
XNCR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
JANX vs. XNCR commentary
Nov 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANX is a StrongBuy and XNCR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 27, 2025
Stock price -- (JANX: $34.74 vs. XNCR: $17.26)
Brand notoriety: JANX and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JANX: 221% vs. XNCR: 69%
Market capitalization -- JANX: $2.09B vs. XNCR: $1.23B
JANX [@Biotechnology] is valued at $2.09B. XNCR’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $109.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JANX’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • JANX’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both JANX and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JANX’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • JANX’s TA Score: 4 bullish, 4 bearish.
  • XNCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than JANX.

Price Growth

JANX (@Biotechnology) experienced а +19.71% price change this week, while XNCR (@Biotechnology) price change was +7.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.60%. For the same industry, the average monthly price growth was -1.29%, and the average quarterly price growth was +72.73%.

Reported Earning Dates

JANX is expected to report earnings on Mar 06, 2026.

XNCR is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+4.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($2.09B) has a higher market cap than XNCR($1.23B). XNCR YTD gains are higher at: -24.891 vs. JANX (-35.114). XNCR has higher annual earnings (EBITDA): -125.38M vs. JANX (-142.8M). JANX has more cash in the bank: 996M vs. XNCR (444M). JANX has less debt than XNCR: JANX (22.2M) vs XNCR (67.9M). XNCR has higher revenues than JANX: XNCR (147M) vs JANX (439K).
JANXXNCRJANX / XNCR
Capitalization2.09B1.23B170%
EBITDA-142.8M-125.38M114%
Gain YTD-35.114-24.891141%
P/E RatioN/AN/A-
Revenue439K147M0%
Total Cash996M444M224%
Total Debt22.2M67.9M33%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JANXXNCR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
JANX
Daily Signal:
Gain/Loss:
XNCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIVBX19.840.22
+1.12%
American Funds International Vntg 529-C
GSSMX36.48N/A
N/A
Goldman Sachs Small Cap Value A
SVUIX40.39N/A
N/A
NAA SMid Cap Value Institutional
ACIHX70.34N/A
N/A
American Century Growth G
BFSIX27.03N/A
N/A
BFS Equity Institutional